Actively Recruiting
Prospective Assessment of Office-Based Ureteroscopy Using a 6.3 French Single Use Digital Flexible Ureteroscope for Upper Tract Urothelial Carcinoma
Led by University of Michigan Rogel Cancer Center · Updated on 2026-10-15
10
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating how well a single use digital, flexible ureteroscope works for assessing upper tract urothelial carcinoma UTUC. This procedure, called ureteroscopy, uses a thin camera to examine patients with known or suspected UTUC. Traditionally done in an operating room under general anesthesia, this study tests performing ureteroscopy in the doctors office using an ultra-thin ureteroscope which may reduce discomfort and avoid anesthesia risks. Participants receive lidocaine jelly inside the urethra for local anesthesia and then undergo ureteroscopy using a 6.3 French single use digital ureteroscope. Pain medication is provided by mouth as needed before and after the procedure. The study focuses on this office-based ureteroscopy procedure as a diagnostic method for UTUC. During the study, participants will be assessed for the success rate of the procedure on the day it is done. Researchers will also monitor pain levels for up to 7-10 days after, patient satisfaction at 7-10 days, and any unplanned healthcare use within 30 days post-procedure. Participation involves completing surveys and adhering to study procedures, with follow-up assessments to evaluate outcomes and experience.
CONDITIONS
Brief Title
Office-Based Ureteroscopy Utilizing a Single Use Digital, Flexible Ureteroscope for Upper Tract Urothelial Carcinoma
Research Team
M
Michael Uy, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here